Those answers are going to be critical as we look at how to sort this out. Obviously it's very important that we have federal action on the research component, but in terms of allowing this treatment, obviously we need to make sure that the appropriate provincial bodies act quickly to allow work such as yours.
The other thing I wanted to get your feedback on is the Multiple Sclerosis Society of Canada. When we had them on the Hill before, I think they had more of a wait-and-see approach toward this treatment. Why do you think that is, to play devil's advocate? Why do you think there's more caution coming from the MS Society?